GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

Developing a Reliable Supplier Evaluation Method for TB Laboratories

A tuberculosis laboratory depends on a steady supply of reagents, culture media, specimen containers, personal protective equipment and other consumables. When a new supplier enters the market, the purchasing decision must extend beyond price and delivery promises. Product quality, technical performance, regulatory status, storage conditions and continuity of supply can all affect test accuracy and patient care.

A documented supplier evaluation method gives laboratory managers a consistent way to compare vendors and approve products. It also supports the quality management system described by the GLI Quality Tool, whose four-phase roadmap links practical improvement activities to twelve Quality Systems Essentials. The method can be scaled for a metropolitan reference laboratory in Melbourne or Sydney, a regional service in Queensland, or a smaller facility managing shipments across remote areas.

Set the purpose and scope

Begin by defining which suppliers and products require formal assessment. The scope may include molecular testing kits, sputum collection materials, stains, culture media, antimicrobial susceptibility testing materials, tubes, pipette tips, filters, disinfectants and waste containers. It should cover both a new vendor and an existing vendor offering a substantially changed product.

The laboratory should describe the risks it is trying to control. A reagent failure may produce invalid results or false reassurance, while a poor-quality consumable may cause contamination, leakage or instrument damage. Some items, such as general stationery, may need only a basic purchasing check. Critical TB diagnostic products require a deeper review involving scientific, technical, safety and procurement personnel.

Write the purpose in operational terms: to select suppliers that can provide safe, compliant, fit-for-purpose products consistently. Assign responsibility for each decision. The laboratory manager may approve the final supplier, while a senior scientist assesses performance, a safety officer checks handling requirements and a procurement officer verifies contracts, pricing and delivery arrangements.

This division of duties is particularly useful in Australian public health services, where purchasing may involve a state-wide tender, a hospital procurement team and a laboratory operating under NATA-accredited processes. Clear roles prevent a low-cost procurement decision from bypassing technical review.

Define supplier and product requirements

Create a standard information request for every prospective supplier. Ask for the manufacturer’s name, product code, version or catalogue number, intended use, instructions for use, lot identification system, expiry period and recommended storage conditions. Request certificates of analysis, safety data sheets, quality certificates and evidence of regulatory clearance where applicable.

For in vitro diagnostic products, check whether the product is appropriate for the intended Australian use and whether the manufacturer or sponsor meets relevant Therapeutic Goods Administration requirements. The laboratory should also confirm whether instructions, labels and safety information are available in a form staff can use correctly. A product designed for another platform, specimen type or workflow should not be accepted simply because it appears similar.

Set measurable acceptance criteria before comparing quotations. These may include minimum remaining shelf life on delivery, acceptable temperature range, packaging integrity, lot traceability, technical support response time and a defined rate of damaged or missing items. Include the laboratory’s need for calibration materials, controls, replacement parts and software updates where these affect testing.

Supply continuity deserves special attention. Australian laboratories may face long transport routes to Darwin, Cairns or regional Western Australia, while imported goods can be affected by customs delays, freight disruptions or limited local stock. Ask suppliers to describe their distribution arrangements, local inventory, back-order process and alternative products. A supplier with a warehouse in Australia may offer greater resilience than one shipping every order internationally, even when the unit price is higher.

Use a risk-based evaluation process

A scoring tool makes evaluations transparent and reduces reliance on personal preference. Use weighted criteria such as product quality, technical suitability, regulatory compliance, supply reliability, storage and transport controls, customer support, cost and sustainability. Assign higher weighting to factors that could directly affect test validity or staff safety.

For example, a critical molecular reagent might receive a weighting of 30 percent for technical performance, 20 percent for supply continuity, 15 percent for regulatory and quality evidence, 15 percent for storage and transport, 10 percent for support and 10 percent for total cost. The exact numbers should reflect the laboratory’s risk assessment. Cost should not compensate for a product that fails essential performance requirements.

Conduct a supplier prequalification review before testing samples. Check the supplier’s quality management certification, recall history, complaint process, change notification policy and ability to provide traceable batch records. Contact existing users where practical, especially laboratories with a similar TB workload. Ask how the supplier handled a failed lot, delayed delivery or urgent replacement.

Then assess the product in the laboratory. Compare a new reagent or consumable with the current approved item using a written verification protocol. Define sample numbers, controls, acceptance limits, operators, instruments and review criteria in advance. For molecular assays, verification may include agreement with known positive and negative materials, invalid rates and performance across relevant specimen types. For culture-related products, examine contamination, growth characteristics, sterility and usability within the established workflow.

The evaluation should include safety and infection prevention. Confirm that packaging withstands transport, containers close securely and materials can be decontaminated or discarded through the laboratory’s approved waste stream. Staff should follow local procedures for cleaning work areas, and a practical surface decontamination aid can support consistent handling after spills, specimen processing or equipment maintenance.

Verify performance and ongoing control

A supplier approval decision should be based on documented evidence rather than a single successful trial. Review product verification results, certificates, delivery samples and relevant correspondence together. Record any deviation, such as a missing temperature indicator, short expiry period or damaged outer carton, and decide whether it requires rejection, conditional approval or corrective action.

For temperature-sensitive products, define how shipments will be checked when received. Staff may need to inspect cold-chain indicators, measure transport temperature, examine packaging and quarantine goods until the responsible person releases them. In Australia’s warmer regions, including northern Queensland and the Northern Territory, transport exposure can be a significant risk. Storage refrigerators and freezers should be monitored, with excursions assessed against the manufacturer’s instructions.

Approval should apply to a specific manufacturer, product, catalogue number and intended use. If the supplier changes the manufacturer, formulation, packaging, production site or transport conditions, require notification and a review. A replacement product may need partial or full re-verification, depending on its risk and similarity to the approved item.

Monitor supplier performance after approval using simple indicators. Track on-time delivery, order completeness, rejected lots, temperature excursions, product complaints, response times and unexpected price changes. Review these data at a defined interval, such as quarterly for critical suppliers and annually for lower-risk vendors. A pattern of small failures can reveal a larger reliability problem before it affects patient testing.

Keep a contingency plan for essential TB materials. Identify an alternative supplier, approved substitute or mutual-aid arrangement with another public health laboratory. This is valuable when a central laboratory in Sydney or Melbourne experiences a national shortage and regional services need to preserve testing capacity. The plan should state who authorises substitution and what verification is required before use.

Document decisions and improve the system

Maintain a supplier file that can be retrieved during an internal audit, accreditation assessment or incident investigation. Include the completed evaluation, risk rating, quotations, regulatory evidence, verification protocol, results, approval signature, contract details and review date. Store current product specifications and instructions where staff can access them, and remove obsolete versions from routine use.

A supplier register should show approval status at a glance. Useful fields include supplier name, contact details, product category, approved product codes, storage requirements, risk level, contract expiry, last performance review and corrective actions. Link the register to inventory controls so that unapproved substitutions cannot be ordered accidentally.

When a supplier fails to meet expectations, use a structured corrective action process. Describe the problem, assess its effect on testing, contain affected stock, notify relevant personnel and seek a response from the supplier. The laboratory may request replacement, a root-cause report or evidence of preventive action. Serious failures may require notification through the laboratory’s incident or quality reporting pathway.

Review the method itself as part of continual improvement. Feedback from scientists, specimen reception staff, stores personnel and procurement teams can show whether the forms are practical and whether important risks are being missed. The GLI Quality Tool’s phased approach helps laboratories start with achievable controls, then strengthen assessment, documentation and improvement activities as resources and experience grow.

Use evaluation records to support purchasing decisions without turning the process into unnecessary administration. A short risk-based form may be sufficient for low-risk consumables, while critical diagnostic reagents deserve a fuller technical review. The aim is a repeatable system that protects result quality, staff safety and service continuity across laboratories with very different operating conditions.

Adopt the method in your laboratory by assigning responsibilities, defining critical product categories, creating a weighted evaluation form and piloting it with the next prospective supplier. Review the first completed assessment with laboratory and procurement staff, record the lessons, and make the approved process part of routine quality management.